Parkinson's Disease In The Crossfire 2009
Past Webcasts
New information for neurologists and other medical professionals broadcast from the Crossfire Studio in Washington, DC.
Current Concepts in Clinical Management 2009
1 hour
Topic segments will include:
Segment 1: Management and Prevention of
Motor Complications
- What are Motor Complications?
- How to Manage Dyskinesias
- Combination Therapies
Segment 2: Cell-Based and Gene Therapies:
Where do we stand?
- Overview of Therapies
- Open-label vs Double-blind Studies
- Future Directions and Clinical Trial Design
- Conclusion
Release Date: May 15, 2009
Expiration Date: May 15, 2011
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Identify the motor complications associated with Parkinson’s Disease and their causes
- Explain the previous treatment options available for managing motor complications
- Discuss the positive and negative aspects of deep brain stimulation
- Explain the positive and negative outcomes associated with studies of cell-based and gene therapies for Parkinson’s Disease
- Explain the rationale for the recommendation to go directly to double-blind clinical studies
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.
Current Concepts in Neuroprotection 2009
1 hour
View topic segments:
Segment 1: Current Concepts in the Etiology and Pathogenesis of PD
- Lewy Body Development in Fetal Nigral Transplantation
- Alpha Synuclein and Protein Folding
- Inflammation and Parkinson’s Disease
Segment 2: The ADAGIO Study: Prospects
for Neuroprotection
- Evaluating Neuroprotection
- ADAGIO Study Endpoints
- Results and Implications
- Future Directions
Release Date: August 1, 2009
Expiration Date: August 1, 2011
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Discuss the pathologic finding in transplanted fetal nigral cells in Parkinson’s Disease patients
- Define the theoretical biologic etiology of Parkinson’s Disease
- Explain the rationale for the Delayed Start protocol
- Describe the endpoints and the outcome of the ADAGIO Study
- Discuss the importance of early diagnosis in terms of effective treatment
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.
Focus on Neuroprotection 2008
1 hour
Release Date: July 1, 2008
Expiration Date: July 1, 2010
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Discuss current concepts related to the etiology and pathogenesis of Parkinson's Disease
- Identify candidate targets and agents for putative neuroprotective drugs
- Identify the positive and negative clinical trials that have been performed to date
- Identify obstacles to development of a neuroprotective therapy
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.
Focus on Treatment 2008
1 hour
View topic segments:
Release Date: April 1, 2008
Expiration Date: April 1, 2010
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Discuss the importance of early diagnosis in terms of effective treatment
- Differentiate the treatment options available for initial treatment of Parkinson's Disease
- Discuss the management of motor complications and identify different treatment modalities
- Identify non-motor features of Parkinson's Disease and their significance in Parkinson's Disease
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.